stockinvestor.com
stockinvestor.com
CRITIC
img-contested
N/A
0 reviews
PUBLIC
img-contested
N/A
0 reviews

RECENT ARTICLES

Sort by:
No Rating
The GOAT in Economics – The Answer May Surprise You | Stock Investor

The GOAT in Economics – The Answer May Surprise You | Stock Investor

“It was the reading of his book that made an ‘economist’ out of me.” — Ludwig von MisesAdvertisement. “I found it such a fascinating book, so satisfying.” — Friedrich Hayek “No book since David Ricardo’s Principles has had such a great influence on the development of economics as…” — Knut Wicksell Yesterday, I made the #1 economics website, “Marginal Revolution”. Here’s the story:  Advertisement. Last week, Tyler Cowen announced on his popular website, that he had published a book called “GOAT: Who is the Greatest Economist in the World and Why It Matters.”...

Oct 26
Share
Save
Review
No Rating
Are You Ready for $250 Oil? | Stock Investor

Are You Ready for $250 Oil? | Stock Investor

This morning, I received a text from a very smart colleague who has substantial investments and expertise in the oil and gas industry. And when this man alerts me to something he thinks I should know, I pay attention. In the text, there was a link to the following CNBC story with this ominous headline: “How oil could spike to $150, even $250 if Israel-Hamas war escalates, according to Bank of America”.Advertisement. Now, one doesn’t even need to read any further to get a bit of a chill down the spine at the prospect of an oil spike of such magnitude. Of course, if you are long oil stocks,...

Oct 26
Share
Save
Review
No Rating
Three Pharmaceutical Stocks to Purchase for Promising Products | Stock Investor

Three Pharmaceutical Stocks to Purchase for Promising Products | Stock Investor

Three pharmaceutical stocks to purchase for promising products poised to profit.Advertisement. The three pharmaceutical stocks purchase stand out even though that sector’s performance has been “underwhelming” compared to the broader market with the S&P 500 up 15.51%, compared to a 6.08% drop for biotechnology stocks in the past year, according to a recent BofA Global Research report. A key reason is that sector rotation in the market has put biotechnology out of favor against a macro-economic scenario of a “soft landing,” according to the BofA report. The focus for investors interested...

Oct 25
Share
Save
Review
No Rating
Global Tension a Catalyst for Energy Assets | Stock Investor

Global Tension a Catalyst for Energy Assets | Stock Investor

Last Tuesday’s release of September retail sales showed a monthly increase of 0.7% and above the 0.3% consensus following an upwardly revised 0.8% increase, from 0.6% in August. Excluding autos, retail sales were higher by 0.6% month over month, compared to a forecast of just 0.2%. Excluding gasoline, retail sales were still higher by 0.7%, and consumers are continuing to spend more than the Fed would prefer.Advertisement. The report is a double-edged sword in that, while the strong retail sales data bodes well for third-quarter GDP forecasts, it weighs on future Fed policy — the...

Oct 23
Share
Save
Review
No Rating
Why Interest Rates Will Remain High for Years | Stock Investor

Why Interest Rates Will Remain High for Years | Stock Investor

Two events scared the living you-know-what out of the markets last week:Advertisement.The last time either happened was July 2007 and August 2000, respectively.There’s a good chance we’ll see a violent snapback in both over the next three-to-six months.However, it won’t last.Advertisement.We explained the heavy debt load weighing down the U.S. government in a previous issue of Wealth Whisperer.Today, we’re taking that a step further.We’ve uncovered new pieces to the puzzle, which have led us to make a bold prediction…Rates will stay at these levels (or slightly higher) for the next...

Oct 23
Share
Save
Review
No Rating
Short-Term, High Grade Corporate Bonds are a Sweet Spot | Stock Investor

Short-Term, High Grade Corporate Bonds are a Sweet Spot | Stock Investor

It’s rare when the Street gets excited about bonds. But after last week’s wink and nod from Jerome Powell that the pause on rates might also mean the Fed is done for the cycle, all classes of bonds ripped higher in reaction. Calls from trading desks around the world to “lock in rates” were resonating throughout all of last week. The combination of last Monday’s Treasury issuance of the less-than-forecast $776 billion for the current quarter, followed by the schedule of shorter maturities that would meet better demand, followed by a dovish Fed policy statement after which was topped off by...

Nov 7
Share
Save
Review
No Rating
The Secret to a 96% Win Rate | Stock Investor

The Secret to a 96% Win Rate | Stock Investor

Imagine boasting a 96%-win rate in your trades.Advertisement. It seems impossible, like turning lead into gold or finding an intelligent Democrat. But for Hugh Grossman and Ahren Stephens, it’s a reality. These seasoned traders, with their impressive track records, have seen fewer losses in six months than most of us have fingers.Advertisement. Naturally, the first time they presented us with their track record, we tried to chase them out for being the black magic witches they were. But the numbers don’t lie. These guys are trading wizards. Source: MidJourney.com Sure, they take a loss from...

Nov 6
Share
Save
Review
  • Total 7 items
  • 1
AUTHORS
Bryan Perry

Bryan Perry

CRITIC
img-contested
N/A
PUBLIC
img-contested
N/A
Jim Woods

Jim Woods

CRITIC
img-contested
N/A
PUBLIC
img-contested
N/A
Mark Skousen

Mark Skousen

CRITIC
img-contested
N/A
PUBLIC
img-contested
N/A
Paul Dykewicz

Paul Dykewicz

CRITIC
img-contested
N/A
PUBLIC
img-contested
N/A